Get started
Author

Karen Bräutigam

Observed names: Bräutigam, Karen, K Bräutigam, K. Bräutigam, K., Bräutigam, KAREN BRÄUTIGAM, Karen Braeutigam, Karen Bräutigam
Observed institutions: University of Bern, Sanford Burnham Prebys Medical Discovery Institute, Christian-Albrechts-Universität zu Kiel, Eisai (Germany), Eli Lilly (Germany), University Hospital Schleswig-Holstein, Universitätsklinikum Aachen, RWTH Aachen University, University of Lübeck
ORCID: 0000-0001-8521-9607
Observed ORCID: 0000-0001-8521-9607
OpenAlex ID: A5046309596
TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells
2003 · Philip Rosenstiel, Massimo Fantini, et al. · Gastroenterology · 423
PDF
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
2015 · Dirk O Bauerschlag, Nicolai Maass, et al. · Journal of Translational Medicine · 129
PDF
Soluble tumor necrosis factor (TNF) receptor‐1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor‐β1
2004 · Georg H. Waetzig, Philip Rosenstiel, et al. · The FASEB Journal · 112
An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
2007 · Ivo Meinhold-Heerlein, Dirk Bauerschlag, et al. · Clinical Cancer Research · 53
Progression-Free Survival in Ovarian Cancer Is Reflected in Epigenetic DNA Methylation Profiles
2011 · Dirk O. Bauerschlag, Ole Ammerpohl, et al. · Oncology · 52
A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion
2008 · Andreas Till, Philip Rosenstiel, et al. · Journal of Cell Science · 52
Toward Homogenous Antibody Drug Conjugates Using Enzyme-Based Conjugation Approaches
2021 · Ahmad Hussain, Armin Grimm, et al. · Pharmaceuticals · 40
PDF
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR
2016 · Verena von Felbert, Dirk Bauerschlag, et al. · Journal of Cancer Research and Clinical Oncology · 36
Reduced hemopexin levels in peritoneal fluid of patients with endometriosis
2013 · Monika M. Wölfler, Ivo M. Meinhold-Heerlein, et al. · Fertility and Sterility · 36
PDF
Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand
2016 · Manal Amoury, Dirk Bauerschlag, et al. · Oncotarget · 33
PDF
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines
2010 · Karen Bräutigam, Julia Biernath-Wüpping, et al. · Journal of Cancer Research and Clinical Oncology · 29
Detection and Specific Elimination of EGFR+ Ovarian Cancer Cells Using a Near Infrared Photoimmunotheranostic Approach
2017 · Dirk Bauerschlag, Ivo Meinhold-Heerlein, et al. · Pharmaceutical Research · 28
PSMD9 expression correlates with recurrence after radiotherapy in patients with cervical cancer
2020 · Frank Köster, Lisa Sauer, et al. · Oncology Letters · 27
PDF
Inhibitors of PD-1/PD-L1 and ERK1/2 impede the proliferation of receptor positive and triple-negative breast cancer cell lines
2021 · Karen Bräutigam, Elodie Kabore-Wolff, et al. · Journal of Cancer Research and Clinical Oncology · 19
PDF
Distribution of HPV Subtypes in Diverse Anogenital and Oral Samples from Women and Correlation of Infections with Neoplasia of the Cervix
2022 · Karen Bräutigam, Stefanie Meier, et al. · Cancers · 18
PDF
Combination of Enzastaurin and Pemetrexed Inhibits Cell Growth and Induces Apoptosis of Chemoresistant Ovarian Cancer Cells Regulating Extracellular Signal-Regulated Kinase 1/2 Phosphorylation
2009 · Karen Bräutigam, Dirk Olaf Bauerschlag, et al. · Translational Oncology · 16
PDF
Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate.
2016 · Karen Bräutigam, Katharina Mitzlaff, et al. · PubMed · 10
Simultaneous and Independent Dual Site-Specific Self-Labeling of Recombinant Antibodies
2018 · Carolin Wollschlaeger, Ivo Meinhold-Heerlein, et al. · Bioconjugate Chemistry · 9
Breakpoint characterization of the der(19)t(11;19)(q13;p13) in the ovarian cancer cell line SKOV‐3
2013 · Wiebke Onkes, Regina Fredrik, et al. · Genes Chromosomes and Cancer · 8
The t(14,15) in mouse strain CBA/CaH-T(14;15)6Ca/J causes a break in the ADAMTS12 gene.
2010 · Bengi Acar-Perk, Karen Bräutigam, et al. · PubMed Central · 6
Effects of PKC beta inhibitor enzastaurin on parental and chemoresistant ovarian cancer cell lines
2006 · I. Meinhold-Heerlein, D. O. Bauerschlag, et al. · Journal of Clinical Oncology · 5
Prognostic and clinical heterogeneity of PD1 and PD-L1- immunohistochemical scores in endometrial cancers
2025 · L. Proppe, T. Jagomast, et al. · Archives of Gynecology and Obstetrics · 4
PDF
Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib
2024 · KAREN BRÄUTIGAM, TALINA SCHMIDT, et al. · Anticancer Research · 4
Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary
2012 · Dirk Bauerschlag, Karen Bräutigam, et al. · Journal of Cancer Research and Clinical Oncology · 4
Translationale Forschung in der gynäkologischen Onkologie: Serum-Tumormarker zur Früherkennung des Ovarialkarzinoms
2008 · I. Meinhold-Heerlein, K. Bräutigam, et al. · Geburtshilfe und Frauenheilkunde · 3
Works count: 60
Citation count: 1,168
H-index: 16
I10-index: 17
Year
Topic
Type